BioNTech to work with Terry Gou's foundation on cancer immunotherapies

The YongLin Healthcare Foundation will partner with BioNTech to develop mRNA-based cancer immunotherapies, according to Terry Gou (郭台銘), founder of the foundation and manufacturing giant Hon Hai Precision Industry Co.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)